PEDIATRICS Vol. 21 No. 1 January 1958, pp. 47-53
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arnold, M. B.
Right arrow Articles by Cope, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arnold, M. B.
Right arrow Articles by Cope, O.

CONCERNING THE CHOICE OF THERAPY FOR CHILDHOOD HYPERTHYROIDISM

Mary B. Arnold M.D.1, Nathan B. Talbot M.D.1, and Oliver Cope M.D.1

1 Departments of Pediatrics and Surgery, Harvard Medical School and the Children's Medical and Surgical Services, Massachusetts General Hospital

Representative experiences with surgical and medical (i.e., propylthiouracil) methods of managing juvenile thyrotoxicosis have been summarized and compared. The findings indicate that these methods are equally capable of eliminating the overt clinical manifestations of Graves' disease and that they yield approximately equal numbers of "cured" patients at the end of a 2-year period. Provided due care is taken, the risk of serious complications due to these forms of treatment also can be kept very low.

While the surgical and medical regimens may be similar in the foregoing respects, they appear to differ considerably in terms of their impact on the life of the patient and his family. One involves a brief period of detailed medical supervision culminating in hospitalization for surgery with its very slight, but definite mortality risk. Thereafter apart from possible need to take a dose of thyroid daily, the patient may be considered essentially normal. By contrast, the other requires that the patient remember to take a dose of medication approximately every 8 hours for a minimum of 2 years. One of these doses may of necessity have to be taken in the middle of the night at an hour when children are normally allowed to sleep undisturbed. Medical therapy also requires that the patient remain accessible to his physician for regulation of dosage and for prompt recognition of drug toxicity, which should be suspected every time the child has a sore throat or fever. It is concluded that these requirements of medical management may in themselves constitute a significant handicap to the child and his parents. It follows that they are deserving of consideration in choosing between subtotal thyroidectomy and prolonged chemotherapy as treatment for children with Graves' disease.

Submitted on June 14, 1957
Accepted on July 25, 1957